Monday, January 30, 2023
Friday, January 27, 2023
Thursday, January 26, 2023
Wednesday, January 25, 2023
Monday, January 23, 2023
Tuesday, January 17, 2023
Investor Ideas #Cannabis #Potcasts 643: Interview with CEO of Tilt Holdings Inc. (OTC: $TLLTF) (NEO: TILT)
Investor Ideas #Cannabis #Potcasts 643: Interview
with CEO of Tilt Holdings Inc. (OTC: $TLLTF) (NEO: TILT)
Delta, Kelowna, BC, January 17, 2023 (Investorideas.com
Newswire), investorideas.com, a global news
source covering leading sectors including marijuana and hemp stocks and its potcast site
release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2023/011723-Cannabis.mp3
Read this in full at https://www.investorideas.com/news/2023/cannabis-potcasts/01171Interview-TLLTF.asp
Hear Investor ideas
cannabis potcast on iTunes
Hear the investor
ideas potcast on Spotify
Today’s podcast overview/transcript:
In today’s podcast Investorideas
interviews Gary Santo, CEO of Tilt
Holdings Inc. (OTC: TLLTF) (NEO:TILT), where we discussed some of the
companies recent news, their 2022 year and how this leads into expectations for
2023, what to look for in brand partnerships as well as how the US market is developing
over all.
Just
last week the company announced that its Chief Executive Officer
Gary Santo has been appointed to the Board of Directors of the National Cannabis Roundtable (“NCR”). Founded
in 2019, NCR is a non-partisan alliance of cannabis companies and ancillary
services and solutions providers working to advance cannabis policy in the
United States.
“The
National Cannabis Roundtable has been and continues to be at the forefront of
federal cannabis policy,” said Gary Santo, TILT’s CEO. “While the industry made
some important gains, including a presidential pardon of all federal
convictions for simple possession of marijuana and the review of the scheduling
of cannabis under federal law, unfortunately, the SAFE Banking Act failed to
pass Congress. The failure of the SAFE Banking Act to pass the Senate shows
once again there is still more work to be done. As a member of the NCR, TILT
will continue to advocate for access to traditional financial services and
capital markets for cannabis businesses, as well as the elimination of tax
barriers such as 280E.”
Continued
Santo, “TILT will fully support NCR’s legislative priorities around
decriminalising cannabis, maintaining business continuity, ensuring consumer and
worker safety, promoting social equity, and remediating harms from
prohibition.”
Santo
joined Tilt Holdings in mid 2020, at the height of COVID, after spending time
at Columbia Care Inc. (OTC:CCHWF) which he later helped take public,
and prior to that his background was in Finance, Healthcare, Life Sciences and
Casino Gaming Equipment.
When
asked about what brought him specifically to Tilt, Santo commented, “Tilt
really was a tremendous platform. We are in a number of states, Massachusetts,
Pennsylvania and Ohio, we have a partnership in New York as well as an entire
part of the business that doesn’t touch the plant out in Arizona, Jupiter
Research, our hardware division, where we provide batteries and cartridges for
cannabis vaping. So we are truly an end to end provider on a business to
business front and I think it puts us in a very unique position in a crowded
market right now.”
Jupiter Research, LLC announced back in November that it had entered
into an agreement with House of Blends Inc. to distribute the Blend Pen™ by Aiden™ in the United States and
Canada.
Aiden’s
patent-pending Blend Pen™ breaks the standard vape mould by holding two
cartridges, side-by-side, within the pen. Each cartridge has adjustable power
outputs, allowing consumers to become their own cannabis mixologists, by
creating unique THC to CBD blends or combining strains to create their hybrid
mixes. Blend Pen™ by Aiden™ also has an accompanying app in development to
track and personalise the consumption experience based on usage information.
It’s anticipated to be in the market for early 2023.
When
asked about how the current cannabis vaping market and how it was affected by
the Pandemic, Santo commented “when people were no longer having to go into the
office, the utility that a vape provides, being able to step outside the
building and take a quick pull and go back, you suddenly didn’t need that
anymore. When the utility dropped away we saw every percentage point for vaping
went down and smokeable flower went up. As we’ve seen a return to the workplace
we’ve seen a return of those all in ones, but we’ve also noticed a change in
the consumer in what they’re trying to vape. Before you had a lot of those
flowery and fruit flavours, but we saw from people smoking the flower a return
to the natural terpenes. So while traditional distillate continues to be a
major part of the vaping industry, we are seeing a movement to less viscous
forms, the waxes, the shatters the butters, that requires a different
technology then what you would use in higher viscosity vaping. That’s where
Jupiter is really at its sweet spot. We distribute C-Cell which uses a ceramic
centre atomizer wrapper with a cotton wick, which provides much more even
heating. We just rolled out three new technologies at MJBiz that are leaning
now towards things like blending, things like less viscous forms of
vaporisation where more natural terpenes are coming into play. I think what we
are seeing is its starting to bifurcate into those who will stay with the high
viscosity distillate and those who are moving into less viscous, more pure
forms that feel more like you’re smoking the actual flower.”
When
asked about the company’s position on brand partnerships and developments,
Santo commented, “we have partnered with brands, so we are not buying them and
becoming a house of brands that we own. We tend to stay away from things like
Celebrity Weed or brands without a lot of depth. If we guess wrong, we are
asset light in that mix so it just means that we will find another brand that
will fit that same product grid and switch to that brand. We aren’t millions of
dollars invested into a brand architecture we might have to reinvent. I think
it's an interesting way to balance all the price compression you see and the
wholesale noise you hear about.”
Tilt announced back in November that it will
launch a cannabis product brand with its partner the Shinnecock Indian Nation, to introduce Little Beach Harvest’s
ancestral plant medicine to Massachusetts. Joining the TILT brand partner
portfolio is in addition to the Shinnecock Nation’s main collaborative effort
with TILT: developing cannabis operations known by the same name, Little Beach
Harvest, on sovereign Shinnecock Nation land in Southampton, NY.
The
established partnership between TILT and the Shinnecock Nation is an integral
component of the product line’s development, with members of the tribal nation
joining TILT’s award-winning cultivation team in overseeing strain selection
and product direction. From seed-to-sale, both the Little Beach Harvest
dispensary and branded product line draw on the Shinnecock Nation’s
centuries-long knowledge of plant medicines and natural healing modalities. The
initial market release will be focused on flower with additional categories
expected to launch throughout 2023. All products will feature a variation of
Little Beach Harvest’s newly established brand look, which includes visual cues
and colours inherently connected with the Shinnecock Nation.
“Little
Beach Harvest naturally fits in TILT’s brand partner portfolio, especially given
the Shinnecock Nation’s ancestral medicinal cannabis connection. We have a
purpose-driven opportunity to bring Indigenous cannabis onto the same stage as
Highsman, Her Highness and Old Pal while also creating a positive impact for a
community historically excluded from and by the cannabis market,” stated TILT’s
Senior Vice President of Marketing and Communications, Amy Larson. “Introducing
the Little Beach Harvest brand beyond New York to other northeast states
increases awareness of the part Indigenous communities are playing in the
cannabis industry.”
TILT
and the Shinnecock Nation announced their partnership in 2021 to create a fully
vertical operation on tribal land that is wholly owned by the Shinnecock
Nation. Funding and business management services are provided by TILT. Groundbreaking of the dispensary took place in
July 2022 and is anticipated to open in early 2023. The 5,000-square-foot
dispensary will be along the main Southampton roadway and will feature
drive-through service.
Speaking
on the difference between Tilt’s 2022 year and expectations for 2023, Santo
commented “I think for 2023, people are cautiously optimistic. When you go back
to 2022 analysts were predicting the usual growth of 30% and then slowly
adjusted. I do think we have gotten so accustomed to ridiculously explosive
growth. It was the only industry I ever saw where people looked at 30% growth
and considered you a laggard. That’s not sustainable. I do think that the
problem with the Investor sentiment is still investor access. This is a high
growth industry. It’s specialty agriculture, specialty manufacturing and
specialty retail all squeezed together into one industry with regulations
differing from State to State. You have to have the right kind of investor
base, not the retail investor. Unfortunately how this market was launched
paired up retail investors with a high growth stock. The amount of capital that
was raised was incredible to me. People were trading on emotion not on the
fundamentals. I’m hoping we can make it a little easier for people to invest
and find capital in the industry.
Santo
also discussed the company’s recent news that the company retired US $7.5
million of its secured promissory notes in the fourth quarter and entered into
amendments to the remaining senior secured promissory notes held by certain
senior noteholders totaling US $2.1 million to extend the maturity dates of
such notes from December 31, 2022 to February 28, 2023. With the payments, the
Company has successfully retired approximately US $33.7 million of the US $35.8
million principal of senior secured notes that were originally scheduled to mature
in November 2022.
The
Company has also signed a fifth amendment to its previously announced
definitive agreement with Innovative Industrial Properties, Inc. (“IIPR”) to
sell and leaseback its White Haven, Pennsylvania facility. With all other
matters for the property already satisfied, the Amendment allows TILT and IIPR
to extend the end of the investigational period of the transaction contemplated
to a date that is on or before February 28, 2023, to coincide with the new debt
facility.
“We
continue to be opportunistic in our approach to addressing our legacy debt
maturities as well as improving our liquidity position. TILT has had to
overcome challenging market conditions to obtain US $40M in non-dilutive
capital earlier this year, which along with available cash on hand has resulted
in retiring 94% of our legacy senior debt,” said TILT’s Chief Executive
Officer, Gary Santo. “At the same time, we have continued to make excellent
progress with new and existing investors in our efforts to finalise the terms
of the refinancing of our remaining legacy debt.”
Santo
went on to discuss the current pricing issues being faced within the industry,
where the industry stock prices are now and where they could be over the next
couple of years, how the cannabis industry has compared to other industries
over the last three years as well as what Tilt has on the horizon for 2023 and
beyond.
To
find out more information about Tilt Holdings click the link here.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the Investorideas.com website and that this podcast is not an
endorsement to buy products or services or securities. Investors are reminded
all investment involves risk and possible loss of investment.
To hear more Investorideas.com
podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also
available on iTunes ( Apple Podcasts) ,
Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Podcasts and most audio platforms
available.
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking
stock news, third party stock research , guest posts and original articles and podcasts in leading stock
sectors. Learn about investing in stocks
and get investor ideas in cannabis,
crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and
more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner ,
Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change ,
Exploring Mining , Betting on Gaming Stocks Podcast and
the
AI Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of
each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing
your news release and our other news services on the Investorideas.com
newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of
each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use
of cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook
https://www.facebook.com/Investorideas
Follow us on YouTube
https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Friday, January 13, 2023
Thursday, January 12, 2023
Wednesday, January 11, 2023
Friday, January 6, 2023
Investor Ideas #Potcasts 642, #Cannabis News and #Stocks on the Move-(TSXV: $KHRN.V) (OTCQX: $KHRNF) (NASDAQ: $VFF)
Investor Ideas #Potcasts 642, #Cannabis News and #Stocks on the Move-(TSXV: $KHRN.V) (OTCQX: $KHRNF) (NASDAQ: $VFF)
Delta, Kelowna, BC, January 6th, 2023 (Investorideas.com
Newswire), investorideas.com, a global news
source covering leading sectors including marijuana and hemp stocks and its potcast site
release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2023/010623-Cannabis.mp3
Read this in full at https://www.investorideas.com/news/2023/cannabis-potcasts/01061KHRN-VFF.asp
Hear Investor ideas
cannabis potcast on iTunes
Hear the investor
ideas potcast on Spotify
Today’s podcast overview/transcript:
In today’s podcast we look at a few
public company announcements, how the overall price of cannabis is becoming an
issue for the industry as well as how legalisation continues to impact cannabis
culture.
Khiron Life
Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) announced that the new Colombian Government
has included plant-based medical cannabis products (i.e., Khiron products) in
the list of mandatory insurance-covered medications starting January 1st, 2023,
as well as the signing of a first-of-its-kind medical cannabis contract with
one of Colombia's largest insurance companies based in the city of Bogota.
Resolution
2808 of 2022 was signed by the Ministry of Health on December 30, 2022. This
revision was necessary to remove unintended ambiguities that had arisen whether
plant-based magistral preparations from medical cannabis (i.e., Khiron
products) were also included in the insurance coverage. This is now once and
for all clearly confirmed. The new government is fully committed with the use
of medical cannabis as a covered treatment under the Colombian health system.
The
Government used this iteration to also validate medical conditions where they
find moderate to strong evidence that cannabis is an effective treatment. These
medical conditions evaluated by the IETS (Technical Institute of the health
Sector) include chronic and neuropathic pain, oncology pain, sleep disorders,
epilepsy, and fibromyalgia, which represent the primary conditions treated with
Khiron products.
During
the first half of 2022, insurance-covered prescriptions represented more than
90% of the Company´s cannabis sales in Colombia. With a patient base of more
than 25,000 patients, Khiron will immediately resume filling insurance-covered
prescriptions through its Zerenia clinic network.
In
addition, Zerenia™ Colombia (Khiron´s wholly owned medical cannabis clinic
network), has entered into a contract to provide "Integrative Health
Services and Pharmacotherapeutic Treatment with Medical Cannabis" with the
largest Government-owned insurance company in the city of Bogota, with more
than 1.2 million insured individuals. This is the first time an insurance
company in Latin America is contracting medical cannabis specific services and
products. This represents an opportunity for Khiron and Zerenia to expand its
client and patient base within Colombia, while continuing to differentiate
itself with its unparalleled expertise in medical cannabis and proprietary
scientific evidence.
Alvaro
Torres, CEO of Khiron, comments: "Today is a great day for patients in
Colombia and Khiron. We welcome the decision from the new Colombian government
to categorically mandate insurance coverage for our medical cannabis products.
With this decision, Khiron will immediately tackle the backlog of covered
medical cannabis products to our patients. In parallel, we have also secured a
first-of-its-kind contractual relationship with one of Colombia´s largest
government-owned insurance companies for medical cannabis specific healthcare
services and dispensation. These two achievements, will allow us to revert to predictable
recurring revenues, shorter collection periods and improved cash flow."
Village Farms
International, Inc. (NASDAQ: VFF) announced further progress on its
international cannabis strategy, and commented that the lack of cannabis
legislative action by the United States Senate (in direct contrast to the 39
States / the District of Columbia with legally sanctioned medical-use and/or
adult-use THC, as well as the vast majority of United States' citizens) while
disappointing, does not impact Village Farms' plans to leverage its
considerable success in Canada into other cannabis markets with greater
regulatory support. Recently, the Company's Canadian Cannabis business, through
its subsidiary, Pure Sunfarms, commenced shipping cannabis products for the
Israeli medical market under an exclusive three-year supply agreement with
Israel-based Dr. Samuelov Importing and Marketing Ltd., doing business as Better Pharma.
Founded
in the early 1990s, Better Pharma is a highly respected importer of
pharmaceuticals and related products for the Israeli market with longstanding
relationships with Israel's retail pharmacies and an extensive sales force and
distribution capabilities, covering over 95% of Israeli independent pharmacies,
as well as retail drug stores.
"Commencing
shipments to Israel is another milestone in our global cannabis strategy,
building on our successes in Canada and Australia," said Michael DeGiglio,
Chief Executive Officer, Village Farms. "We are proud and privileged to
partner exclusively with Better Pharma for the significant medical cannabis
opportunity in Israel and are confident that Pure Sunfarms unique
"Everyday Premium" positioning, which has proven so successful in
Canada and Australia, will be differentiated in the Israeli market, and
well-received by patients."
"Our
agreement with Better Pharma marks the first time Pure Sunfarms branded flower,
inclusive of Canada's top-selling Pink Kush, makes its way to consumers
internationally," said Mandesh Dosanjh, President and CEO, Pure Sunfarms.
"We're confident that Better Pharma, an organisation that shares our
belief in a brand-led consumer approach, will help patients in Israel come to
know and appreciate Pure Sunfarms high-quality, BC grown strains as much as
Canadians have."
"We
are proud and honoured to exclusively partner with Pure Sunfarms, Canada's No.1
flower brand and market leader, for medical cannabis products," said Ran
Samuelov, Chief Executive Officer, Better Pharma. "We are confident we
will be able to leverage our knowledge and expertise in international brand
management for Pure Sunfarms to become one of the leading medical cannabis
brands in Israel. We are looking forward to delivering Pure Sunfarms unique and
differentiated "Everyday Premium" brand proposition to Israeli
medical patients and pharmacists."
Sales
of Pure Sunfarms product to patients in Israel are expected to commence later
this month. Initial strains offered will include Pink Kush, Jet Fuel Gelato,
and Sakura Punch (sold as Black Cherry Punch in Canada).
Village
Farms continues to execute on its global cannabis strategy, which includes
accelerated sales to the Australian medical market and plans to launch in the
German medical market.
In
a recent Bloomberg article titled, Cheap Weed Has
Become a Big Problem in the Pot Industry, the overall price of
cannabis is implied to be a growing issue for both the legal and legacy markets
as the two cannibalise one another over price.
The
article states that “If you thought regulatory issues were the cannabis
industry’s biggest challenges going into 2023, take a closer look at the price
of raw marijuana flower. Retail and wholesale prices have fallen as competition
with the black market puts pressure on legal retailers to keep prices low, and
this is making it hard for growers to get the supply-demand balance right.”
“The
industry today is facing a number of headwinds. The most existential is
pricing,” said Rick Maturo, director of insights and intelligence for
cannabis-data firm BDSA,
during a webinar last week.
The
retail price of a gram of marijuana dropped 13% to $9.43 in the third quarter
of 2022 from $10.83 in the same period a year earlier — the steepest fall ever
seen for marijuana in a 12-month period, according to BDSA. Wholesale price
declines were even more dramatic, especially in more “mature” markets that have
had legal programs for longer, BDSA data shows. In Colorado, the average price
per pound has declined 51% since the fourth quarter of 2020. In Oregon, it’s
down 36%.
While
there is heavy competition for lower priced products in the legal market, and
yes this is heavily influenced by the existence of the legacy market, the
underlying cause for concern is still primarily cost of operations and
licensing.
One
also has to consider what the implications could be of an eventual globalised
market where products from South America could be in play, where production can
get as low as $0.50 a gram.
This
also ignores the fact that in many established markets, high priced
concentrates and true “premium bud” have continued to grow their overall market
share and are slowly taking more and more sales away from low-cost bulk
products. This is also an area of the legal market where the legacy market has
difficulty competing due to the high quality nature of the extraction and grow
facilities where these products are made which cannot be replicated or properly
established in the legacy market.
A
recent CBC article discussed how cannabis
counter-culture has been impacted as “one of the oldest stores selling smoking
paraphernalia in Ottawa, will be closing its doors for good in the spring.”
Mike
Foster opened the head shop in Westboro in 1992 before moving to its location
in the Glebe in 1997. The iconic cannabis counterculture store has been seen as
an institution in the city.
Foster
was involved in efforts to legalise cannabis because he said he didn't want to
see people getting arrested for using the drug, but its legislation also led to
the growth of larger retail operations catering to cannabis aficionados.
"The
proliferation of cannabis shops certainly affected our sales on smoking
accessories," he said.
"Once
legalisation happened, our sales plummeted. There's so many stores out there
now, like every few blocks there's a cannabis shop and you can buy your papers
or pipes there. So that aspect of our business suffered."
Despite
the challenges, Foster doesn't have any regrets about supporting legalisation
efforts.
"I
was still happy to see progress being made in that regard."
David
Soberman, a professor of marketing at the Rotman School of Management at the
University of Toronto, said stores like Crosstown Traffic have lost the
"forbidden fruit appeal" they had when cannabis was prohibited.
Head
shops had a "rebellious" nature that drew people in, Soberman said,
working in the margins between legal and illegal.
"Legalisation
kind of takes a bit of a romance out of the whole cannabis counter culture
rebellion," Foster agreed.
What
this article does not take into account however is that competition also
exposes flaws. One of the aspects many legacy consumers have come to realise is
that now that there are more options available, when it comes to aspects like
inventory management, quality control, proper staffing, proper staff training
and overall business functionality, many legacy stores and growers were
underdelivering due to the lack of competition.
While
legalisation has certainly changed the culture, if you want to maintain some of
the counterculture aspects you can easily find examples of this aspect alive
and well when you look at the heady glass scene in the US and Canada or the
resurgence of psychedelics.
In
order for cannabis to be able to compete with prescription medications as a
medicine, which have lead to a corrupt medical system and a health epidemic in
North America, or with alcohol as a social lubricant, which is one of the
leading causes of domestic violence, emergency room calls and driving
accidents, the culture has to change.
Cannabis
for everyone, is in every way a positive move for the world. If you find
yourself disheartened by the “taboo” factor of this plant being removed, then
you have to ask yourself what was the culture you were really endorsing to
begin with? Was it simply rebellion and uniqueness for their own sake, or was
the goal from the start to get to a point where society returns to seeing
cannabis as what it is, a plant that is extremely beneficial to humanity?
We
all get upset when that obscure band we love suddenly has a hit that everyone
knows and your secret club is ruined by a mass audience, but with cannabis, more
access and a wider audience has the ability to change the overall culture in a
positive way.
With
both cannabis and psychedelics, once you have a truly potent experience, a part
of you is changed, and changed mostly in a positive way. These plants still
have the ability to teach all of us how to move into a less disastrous future,
and so if we have to lose some of the “cool” factor, then that is a small price
to pay for overall evolution.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the Investorideas.com website and that this podcast is not an
endorsement to buy products or services or securities. Investors are reminded
all investment involves risk and possible loss of investment.
About
Investorideas.com - Big Investing Ideas
We publish breaking
stock news, stock research, guest posts and create original top rated investing
podcasts, plus sector tag articles featuring up and coming companies and
industry leaders. Investor Idea’s
original branded content includes the Crypto
Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock
directories for AI and tech, biotech, cannabis, cleantech, crypto, defense,
gaming, health and wellness, mining, oil and gas, sports and water.
The Investorideas.com podcasts are also available on Apple Podcasts
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio, Google Podcasts
and most audio platforms available.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing
your news release and our other news services on the Investorideas.com
newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use
of cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook
https://www.facebook.com/Investorideas
Follow us on YouTube
https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Subscribe to:
Posts (Atom)